These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30195197)

  • 1. Alpha-synuclein aggregates in the parotid gland of idiopathic REM sleep behavior disorder.
    Fernández-Arcos A; Vilaseca I; Aldecoa I; Serradell M; Tolosa E; Santamaría J; Gelpi E; Iranzo A
    Sleep Med; 2018 Dec; 52():14-17. PubMed ID: 30195197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein aggregates in labial salivary glands of idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A; Borrego S; Vilaseca I; Martí C; Serradell M; Sánchez-Valle R; Kovacs GG; Valldeoriola F; Gaig C; Santamaria J; Tolosa E; Gelpi E
    Sleep; 2018 Aug; 41(8):. PubMed ID: 29790977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
    Knudsen K; Fedorova TD; Hansen AK; Sommerauer M; Otto M; Svendsen KB; Nahimi A; Stokholm MG; Pavese N; Beier CP; Brooks DJ; Borghammer P
    Lancet Neurol; 2018 Jul; 17(7):618-628. PubMed ID: 29866443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
    Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
    Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients.
    Antelmi E; Pizza F; Donadio V; Filardi M; Sosero YL; Incensi A; Vandi S; Moresco M; Ferri R; Marelli S; Ferini-Strambi L; Liguori R; Plazzi G
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1872-1876. PubMed ID: 31386270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Vilas D; Iranzo A; Tolosa E; Aldecoa I; Berenguer J; Vilaseca I; Martí C; Serradell M; Lomeña F; Alós L; Gaig C; Santamaria J; Gelpi E
    Lancet Neurol; 2016 Jun; 15(7):708-718. PubMed ID: 27039162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REM sleep behavior disorder and neuropathology in Parkinson's disease.
    Postuma RB; Adler CH; Dugger BN; Hentz JG; Shill HA; Driver-Dunckley E; Sabbagh MN; Jacobson SA; Belden CM; Sue LI; Serrano G; Beach TG
    Mov Disord; 2015 Sep; 30(10):1413-7. PubMed ID: 26265105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.
    Högl B; Stefani A; Videnovic A
    Nat Rev Neurol; 2018 Jan; 14(1):40-55. PubMed ID: 29170501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Iranzo A; Stefani A; Serradell M; Martí MJ; Lomeña F; Mahlknecht P; Stockner H; Gaig C; Fernández-Arcos A; Poewe W; Tolosa E; Högl B; Santamaria J;
    Neurology; 2017 Jul; 89(3):242-248. PubMed ID: 28615430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?
    Wood H
    Nat Rev Neurol; 2016 May; 12(5):249. PubMed ID: 27080519
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder.
    Antelmi E; Donadio V; Incensi A; Plazzi G; Liguori R
    Neurology; 2017 May; 88(22):2128-2131. PubMed ID: 28468843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease.
    Doppler K; Mammadova S; Kuzkina A; Reetz K; Michels J; Hermann W; Sommerauer M; Volkmann J; Oertel WH; Janzen A; Sommer C
    Parkinsonism Relat Disord; 2022 Jun; 99():58-61. PubMed ID: 35605512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNCA Hypomethylation in Rapid Eye Movement Sleep Behavior Disorder Is a Potential Biomarker for Parkinson's Disease.
    Zhao A; Li Y; Niu M; Li G; Luo N; Zhou L; Kang W; Liu J
    J Parkinsons Dis; 2020; 10(3):1023-1031. PubMed ID: 32444558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
    Al-Qassabi A; Tsao TS; Racolta A; Kremer T; Cañamero M; Belousov A; Santana MA; Beck RC; Zhang H; Meridew J; Pugh J; Lian F; Robida MD; Ritter M; Czech C; Beach TG; Pestic-Dragovich L; Taylor KI; Zago W; Tang L; Dziadek S; Postuma RB
    Mov Disord; 2021 Apr; 36(4):895-904. PubMed ID: 33232556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.
    Sprenger FS; Stefanova N; Gelpi E; Seppi K; Navarro-Otano J; Offner F; Vilas D; Valldeoriola F; Pont-Sunyer C; Aldecoa I; Gaig C; Gines A; Cuatrecasas M; Högl B; Frauscher B; Iranzo A; Wenning GK; Vogel W; Tolosa E; Poewe W
    Neurology; 2015 Nov; 85(20):1761-8. PubMed ID: 26475692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
    J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Rapid Eye Movement Sleep Behavior Disorder to Parkinson's Disease: Possible Predictive Markers of Conversion.
    Zhou L; Zhu L; Liu J
    ACS Chem Neurosci; 2019 Feb; 10(2):824-827. PubMed ID: 30222303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.